Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Ivanovich

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Translational Behavioral Medicine|February 1, 2018
Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factorsKimberly A Kaphingst, Jennifer Ivanovich, Sarah Lyons, et al.
Aging Cell|September 19, 2007
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndromeHong-Yan Du, Rachel Idol, Sara Robledo, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Blood|October 22, 2008
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurementsHong-Yan Du, Elena Pumbo, Jennifer Ivanovich, et al.
Science (New York, N.Y.)|June 27, 2009
DICER1 mutations in familial pleuropulmonary blastomaD Ashley Hill, Jennifer Ivanovich, John R Priest, et al.
Cancer Medicine|December 22, 2015
Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancerShariq S Khwaja, Jennifer Ivanovich, Todd A DeWees, et al.
American Journal of Human Genetics|July 5, 2003
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathwayXiao-Ping Zhou, Kristin A Waite, Robert Pilarski, et al.
F1000Research|May 17, 2018
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / <i>DICER1</i> syndrome: a unique variant of the two-hit tumor suppression modelMark Brenneman, Amanda Field, Jiandong Yang, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Translational Behavioral Medicine|February 1, 2018
Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factorsKimberly A Kaphingst, Jennifer Ivanovich, Sarah Lyons, et al.
Aging Cell|September 19, 2007
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndromeHong-Yan Du, Rachel Idol, Sara Robledo, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Blood|October 22, 2008
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurementsHong-Yan Du, Elena Pumbo, Jennifer Ivanovich, et al.
Science (New York, N.Y.)|June 27, 2009
DICER1 mutations in familial pleuropulmonary blastomaD Ashley Hill, Jennifer Ivanovich, John R Priest, et al.
Cancer Medicine|December 22, 2015
Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancerShariq S Khwaja, Jennifer Ivanovich, Todd A DeWees, et al.
American Journal of Human Genetics|July 5, 2003
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathwayXiao-Ping Zhou, Kristin A Waite, Robert Pilarski, et al.
F1000Research|May 17, 2018
Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / <i>DICER1</i> syndrome: a unique variant of the two-hit tumor suppression modelMark Brenneman, Amanda Field, Jiandong Yang, et al.
JAMA|April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AMLDaniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Pageof 3